Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Experimental and Clinical Endocrinology and Diabetes is Scopus-indexed (Q2, CiteScore 3.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Georg Thieme Verlag.
Checked against the index lists dated .
ISSN 0947-7349Verify ISSN ↗1439-3646Verify ISSN ↗
Publisher: Georg Thieme Verlag
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 76 / 179 | 57th | Q2 |
| Endocrinology, Diabetes and Metabolism | 140 / 250 | 44th | Q3 |
| Endocrinology | 88 / 132 | 33rd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1983–present, best quartile Q2, CiteScore 3.9.
Experimental and Clinical Endocrinology and Diabetes is Q2 in Internal Medicine (rank 76 of 179), Q3 in Endocrinology, Diabetes and Metabolism (rank 140 of 250) and Q3 in Endocrinology (rank 88 of 132), by CiteScore 2025.
Experimental and Clinical Endocrinology and Diabetes is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.9, which places it in quartile Q2 at the 57th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.529, quartile Q2, with an H-index of 92.
Experimental and Clinical Endocrinology and Diabetes is published by Georg Thieme Verlag. Its print ISSN is 0947-7349 and its online ISSN is 1439-3646.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Experimental and Clinical Endocrinology and Diabetes has an h-index of 99 and a 2-year mean of 1.67 citations per paper (OpenAlex). Its Scopus CiteScore is 3.9, quartile Q2. On 2-year citations it ranks #84 of 172 Scopus journals in Internal Medicine.
Experimental and Clinical Endocrinology and Diabetes published 62 papers in 2025; its busiest recent year was 2018 with 160. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2024–2026), authors are most often from Germany (22.4%), Türkiye (16.3%) and China (13.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.